MiniMed Group, Inc. MMED
18.85 USD -0.05 (-0.26%)
At closeNov 3, 2026, 4:01 PM EST
18.20 -0.65 -3.45%
After hours · Nov 3, 4:01 PM ET
18.51 Day range 19.05
10.65 52-week range 24.43
- YTD
- +1.95%
- 1 year
- +1.95%
Analyst view
Consensus: buy
Buy
Price target (mean) 25.47 +35.1% upside
Now 18.85
- Target (low)
- 15.00
- Target (mean)
- 25.47
- Target (high)
- 30.00
Ratings (0m) 16 12 buy · 3 hold · 1 sell
- Strong buy0
- Buy12
- Hold3
- Sell0
- Strong sell1
Recommendation trend
- This month 16
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.10105 | 0.06355 – 0.14 | 0.00 | 0.0% | 824.44M | 0.0% | 10 |
| Next quarter | 0.20508 | 0.18 – 0.22136 | 0.0752 | +172.7% | 860.58M | +8.9% | 10 |
| Current year | 0.70007 | 0.62 – 0.76579 | -0.5573 | +225.6% | 3.44B | +16.3% | 11 |
| Next year | 0.69446 | 0.40 – 0.97 | 0.70007 | -0.8% | 3.73B | +8.5% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Jefferies | Initiated | — | Hold |
| Oct 8, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Barclays | Initiated | — | Equal-Weight |
| Sep 24, 2026 | Truist Securities | Initiated | — | Buy |
| Sep 3, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 2, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Sep 2, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 2, 2026 | UBS | Maintained | Buy | Buy |
| Sep 2, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Sep 2, 2026 | B of A Securities | Maintained | Buy | Buy |
| Sep 1, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 18, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 12, 2026 | Benchmark | Initiated | — | Buy |
| Apr 1, 2026 | Barclays | Initiated | — | Overweight |
| Mar 31, 2026 | William Blair | Initiated | — | Outperform |
| Mar 31, 2026 | Citigroup | Initiated | — | Buy |
| Mar 31, 2026 | Piper Sandler | Initiated | — | Neutral |
| Mar 31, 2026 | Mizuho | Initiated | — | Outperform |
| Mar 31, 2026 | Wells Fargo | Initiated | — | Overweight |
| Mar 31, 2026 | Morgan Stanley | Initiated | — | Overweight |
| Mar 31, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| Mar 31, 2026 | B of A Securities | Initiated | — | Buy |
| Mar 31, 2026 | BTIG | Initiated | — | Buy |